The crypto assets sector has recently revealed an astonishing eyewash that has been conducted in secret, involving several well-known tokens such as SUI, NEAR, Axelar, and SEI. This eyewash has siphoned off over $50 million in investments in just a few months, with victims including venture capitalists, industry opinion leaders, and even significant investors with substantial crypto assets. Surprisingly, this eyewash garnered almost no discussion before it was widely discovered.

The eyewash began in November 2024, when a series of highly attractive trading opportunities suddenly appeared in the Crypto Assets OTC market. In Telegram groups, multiple investment groups and private investment pools began to promote so-called high-quality OTC trades. They claimed they could sell tokens of well-known projects such as Graph (GRT), Aptos (APT), SEI, SWELL, etc., for half the market price, with the only condition being that investors needed to accept a 4-5 month lock-up period.

These seemingly incredible offers have caused a stir in the Crypto Assets market. Although some investors are skeptical about this, the enticing low prices have still attracted the attention of many. In this field where risks and opportunities coexist, such generous conditions have undoubtedly stirred the interest and greed of many.

However, like the beginnings of many eyewash schemes, these transactions hide carefully designed traps. The scammers exploited investors' desire for high returns and the trust in well-known projects to set up this clever eyewash. This not only exposes the blindness of certain investors but also highlights the lack of regulation and risk awareness in the Crypto Assets market.

This incident once again reminds us that in the rapidly evolving world of Crypto Assets, opportunities and risks coexist. Investors need to remain highly vigilant and be especially cautious of trades that seem too good to be true. At the same time, this also highlights the importance of strengthening market regulation and improving investor education to prevent the recurrence of similar eyewash.